Early Evaluation of Immunotherapy Response in Lymphoma Patients by 18F-FDG PET/CT: A Literature Overview

Immunotherapy is a promising therapeutic strategy both for solid and hematologic tumors, such as in Hodgkin (HL) and non-Hodgkin lymphoma (NHL). In particular, immune-checkpoint inhibitors, such as nivolumab and pembrolizumab, are increasingly used for the treatment of refractory/relapsed HL. At the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrari, Cristina, Maggialetti, Nicola, Masi, Tamara, Nappi, Anna Giulia, Santo, Giulia, Niccoli Asabella, Artor, Rubini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002936/
https://www.ncbi.nlm.nih.gov/pubmed/33803667
http://dx.doi.org/10.3390/jpm11030217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002936/
https://www.ncbi.nlm.nih.gov/pubmed/33803667
http://dx.doi.org/10.3390/jpm11030217

Ejemplares similares